Both in Pharmaceuticals
ALX Oncology Holdings vs Niagen Bioscience
Over the past year ALXO returned −17.8% and NAGE returned −67.4%; their daily moves had a correlation of 0.17.
ALXO −17.8% NAGE −67.4%Growth of $1, one year, split-adjusted
| Metric | ALXO | NAGE |
|---|---|---|
| Price | $1.29 | $2.36 |
| Market cap | $178.4M | $186.7M |
| Today | −5.84% | −1.67% |
| 1 month | +6.6% | −11.9% |
| 6 months | −33.2% | −51.0% |
| Year to date | +14.2% | −62.9% |
| 1 year | −16.2% | −68.7% |
| Revenue growth (YoY) | — | −4.3% |
| Gross margin | — | 64.8% |
| Net margin | — | 3.2% |
| P/E (TTM) | — | 11.7× |
| Price / sales | — | 1.4× |
| Net cash | $128.5M | $66.7M |
| Dividend yield | — | — |
| Volatility (60d) | 93.1% | 37.2% |
| Short % of float | 6.5% | 8.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).